DA
BIIB icon

DSC Advisors’s Biogen BIIB Stock Holding History

DSC Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-14,078
Closed -$4.41M – 56
2016
Q3 		$4.41M Sell
14,078
-6
-0% -$1.78K 2.68% 15
2016
Q2 		$3.4M Sell
14,084
-5
-0% -$1.32K 2.14% 19
2016
Q1 		$3.67M Sell
14,089
-22
-0.2% -$5.81K 2.18% 16
2015
Q4 		$4.32M Buy
+14,111
New +$4.05M 2.26% 14

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DSC Advisors's BIIB Position: Q4 2016 in Review

DSC Advisors sold out of Biogen (BIIB) in Q4 2016, closing a stake of 14,078 shares — an estimated $4.41M sold.

DSC Advisors first reported a position in BIIB in Q4 2015 and held it in 4 quarters. The position peaked at $4.41M in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • DSC Advisors reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • DSC Advisors sold 14,078 Biogen shares in Q4 2016, an estimated $4.41M.
  • DSC Advisors first reported a position in Biogen in Q4 2015 and held it in 4 quarters.
  • DSC Advisors's Biogen position peaked at $4.41M in Q3 2016.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on DSC Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.